233 related articles for article (PubMed ID: 29751213)
1. From human antibody structure and function towards the design of a novel Plasmodium falciparum circumsporozoite protein malaria vaccine.
Wardemann H; Murugan R
Curr Opin Immunol; 2018 Aug; 53():119-123. PubMed ID: 29751213
[TBL] [Abstract][Full Text] [Related]
2. Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs.
Murugan R; Scally SW; Costa G; Mustafa G; Thai E; Decker T; Bosch A; Prieto K; Levashina EA; Julien JP; Wardemann H
Nat Med; 2020 Jul; 26(7):1135-1145. PubMed ID: 32451496
[TBL] [Abstract][Full Text] [Related]
3. Liver-Directed AAV8 Booster Vaccine Expressing
Shahnaij M; Iyori M; Mizukami H; Kajino M; Yamagoshi I; Syafira I; Yusuf Y; Fujiwara K; Yamamoto DS; Kato H; Ohno N; Yoshida S
Front Immunol; 2021; 12():612910. PubMed ID: 34248928
[TBL] [Abstract][Full Text] [Related]
4. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE
PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750
[TBL] [Abstract][Full Text] [Related]
5. A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.
Zhang M; Kaneko I; Tsao T; Mitchell R; Nardin EH; Iwanaga S; Yuda M; Tsuji M
Malar J; 2016 Apr; 15():201. PubMed ID: 27068454
[TBL] [Abstract][Full Text] [Related]
6. The challenges of a circumsporozoite protein-based malaria vaccine.
Chatterjee D; Cockburn IA
Expert Rev Vaccines; 2021 Feb; 20(2):113-125. PubMed ID: 33554669
[TBL] [Abstract][Full Text] [Related]
7. How to induce protective humoral immunity against Plasmodium falciparum circumsporozoite protein.
Wahl I; Wardemann H
J Exp Med; 2022 Feb; 219(2):. PubMed ID: 35006242
[TBL] [Abstract][Full Text] [Related]
8. Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection.
Scally SW; Murugan R; Bosch A; Triller G; Costa G; Mordmüller B; Kremsner PG; Sim BKL; Hoffman SL; Levashina EA; Wardemann H; Julien JP
J Exp Med; 2018 Jan; 215(1):63-75. PubMed ID: 29167197
[TBL] [Abstract][Full Text] [Related]
9. Editorial: The First Monoclonal Antibody Vaccine to Prevent Malaria Heralds a New Era of Malaria Vaccines to the Plasmodium falciparum Circumsporozoite Protein (PfCSP).
Parums DV
Med Sci Monit; 2021 Sep; 27():e934676. PubMed ID: 34511592
[TBL] [Abstract][Full Text] [Related]
10. Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse
Noe AR; Terry FE; Schanen BC; Sassano E; Hindocha P; Phares TW; Moise L; Christen JM; Tucker KD; Kotraiah V; Drake DR; Martin WD; De Groot AS; Gutierrez GM
Front Immunol; 2021; 12():689920. PubMed ID: 34168657
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite protein.
Iyori M; Nakaya H; Inagaki K; Pichyangkul S; Yamamoto DS; Kawasaki M; Kwak K; Mizukoshi M; Goto Y; Matsuoka H; Matsumoto M; Yoshida S
PLoS One; 2013; 8(8):e70819. PubMed ID: 23951015
[TBL] [Abstract][Full Text] [Related]
12. RTS,S/AS02A Malaria Vaccine-Induced IgG Responses Equally Recognize Native-Like Fucosylated and Nonfucosylated Plasmodium falciparum Circumsporozoite Proteins.
Jairoce C; Macià D; Torres-Yaguana JP; Mayer L; Vidal M; Santano R; Hurtado-Guerrero R; Reiter K; Narum DL; Lopez-Gutierrez B; Hamerly T; Sacarlal J; Aguilar R; Dinglasan RR; Moncunill G; Izquierdo L; Dobaño C
J Infect Dis; 2024 Mar; 229(3):795-799. PubMed ID: 37889513
[TBL] [Abstract][Full Text] [Related]
13. Down-selecting circumsporozoite protein-based malaria vaccine: A comparison of malaria sporozoite challenge model.
Amelia F; Iyori M; Emran TB; Yamamoto DS; Genshi K; Otsuka H; Onoue Y; Yusuf Y; Islam A; Yoshida S
Parasite Immunol; 2019 May; 41(5):e12624. PubMed ID: 30883819
[TBL] [Abstract][Full Text] [Related]
14. Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection.
Foquet L; Hermsen CC; van Gemert GJ; Van Braeckel E; Weening KE; Sauerwein R; Meuleman P; Leroux-Roels G
J Clin Invest; 2014 Jan; 124(1):140-4. PubMed ID: 24292709
[TBL] [Abstract][Full Text] [Related]
15. Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate.
Mohamed NS; AbdElbagi H; Elsadig AR; Ahmed AE; Mohammed YO; Elssir LT; Elnour MB; Ali Y; Ali MS; Altahir O; Abubakr M; Siddig EE; Ahmed A; Omer RA
Malar J; 2021 Nov; 20(1):436. PubMed ID: 34758827
[TBL] [Abstract][Full Text] [Related]
16. Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein.
Wang R; Epstein J; Charoenvit Y; Baraceros FM; Rahardjo N; Gay T; Banania JG; Chattopadhyay R; de la Vega P; Richie TL; Tornieporth N; Doolan DL; Kester KE; Heppner DG; Norman J; Carucci DJ; Cohen JD; Hoffman SL
J Immunol; 2004 May; 172(9):5561-9. PubMed ID: 15100299
[TBL] [Abstract][Full Text] [Related]
17. Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.
Chinchilla M; Pasetti MF; Medina-Moreno S; Wang JY; Gomez-Duarte OG; Stout R; Levine MM; Galen JE
Infect Immun; 2007 Aug; 75(8):3769-79. PubMed ID: 17502396
[TBL] [Abstract][Full Text] [Related]
18. RTS,S/AS01 malaria vaccine mismatch observed among Plasmodium falciparum isolates from southern and central Africa and globally.
Pringle JC; Carpi G; Almagro-Garcia J; Zhu SJ; Kobayashi T; Mulenga M; Bobanga T; Chaponda M; Moss WJ; Norris DE
Sci Rep; 2018 Apr; 8(1):6622. PubMed ID: 29700348
[TBL] [Abstract][Full Text] [Related]
19. A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII.
Shiratsuchi T; Rai U; Kaneko I; Zhang M; Iwanaga S; Yuda M; Tsuji M
Vaccine; 2017 Dec; 35(50):6990-7000. PubMed ID: 29089194
[TBL] [Abstract][Full Text] [Related]
20. Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies.
Kratochvil S; Shen CH; Lin YC; Xu K; Nair U; Da Silva Pereira L; Tripathi P; Arnold J; Chuang GY; Melzi E; Schön A; Zhang B; Dillon M; Bonilla B; Flynn BJ; Kirsch KH; Kisalu NK; Kiyuka PK; Liu T; Ou L; Pancera M; Rawi R; Reveiz M; Seignon K; Wang LT; Waring MT; Warner J; Yang Y; Francica JR; Idris AH; Seder RA; Kwong PD; Batista FD
Immunity; 2021 Dec; 54(12):2859-2876.e7. PubMed ID: 34788599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
